the team

The Board

Roger Killen

Roger is a healthcare entrepreneur founding The
Learning Clinic and Dr Foster selling into the NHS.

Prof. Andrew Shaw
CEO & Founder

Attomarker is Prof Shaw’s second spinout company, the first having been sold for $8M. He will move to Chief Scientist when the next round is closed

Nigel Clarke

Nigel is and experienced Chair of a start-up companies and is Chair of the UK Pharmacy Regulator (GPC)

Griff Williams
NED, British Innovation Fund

Griff is the Chief Investment Officer of The British Innovation Fund that made the £3m Series A investment in Attomarker

Sandy Primrose

Experienced Biotech entrepreneur as Chair and Director for many companies leading to trade sales

Yves Le Goff
Strategic Adviser and CCO,
EU Markets

Yves co-led Attomarker’s GBP1.5m Future Fund 2020 funding round. He is a former investment banker (Goldman Sachs, Credit Suisse) and early-stage investor

Senior Team

Dr. Jonathan Snicker
Chief Strategy Officer

20+ years experience in variety of roles spanning university academia, business development, philanthropy, strategic, political, comms and funding advisory

Andrew Vincent
Global Marketing Director

20+ years’ experience in international strategic & operational healthcare marketing and business development. Director of Integra Healthcare Ltd

Robert Warner

Chartered Accountant from KPMG, with 20 years’ experience as a commercial CFO, gained across a variety of rapid-scale international businesses in diverse sectors

Jonathan Collins
General Counsel

Seasoned lawyer with international corporate and commercial experience. Previously: Jones Day, JP Morgan and Jardine Matheson